Biogen and Invitae Announce Availability of Rapid Results in Genetic Testing Program for Spinal Muscular Atrophy (SMA) to Improve Speed of Diagnosis for Patients

    NEXT STORY
    Delcath Systems Closes $9.5 Million Private Placement
    PREV STORY
    uniQure Announces Leadership Promotions and Executive Transition
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Immune Design Presents Data on the Mechanism of Action of G100 via TLR4 Expressed in B Cell Malignancies at the Inaugural AACR International Meeting Advances in Malignant Lymphoma

    - G100 directly targets and modifies TLR4 expressing malignant B cells making them more ...

    author_avatar
    NASDAQ Market News

    DGAP-News: AiCuris Anti-infective Cures GmbH: Two Recent Publications on Pritelivir Confirm the Potency of the Novel AiCuris Anti-Herpes Simplex Virus Drug

    DGAP-News: AiCuris Anti-infective Cures GmbH / Key word(s): Scientific publication AiCuris Anti-infective Cures GmbH: ...

    author_avatar
    NASDAQ Market News

    GeoVax Zika Vaccine Study Published in the Atlas of Science

    GeoVax Zika Vaccine Provides Potential for 100% Protection & Reduced Side-Effect Risks ATLANTA, GA, ...

    author_avatar
    NASDAQ Market News